Several studies have shown an increase in the proportion of CD4+/CD8+ T cells in PMN patients, with the CD4+/CD8+ ratio gradually decreasing with the clinical remission of nephropathy [16–17]. The gene discussed is CD8A; the disease is kidney disorder.